- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06905470
Effekterna av excentrisk jämfört med standardstyrkaträning i rehabilitering av primär ryggmärgsskada (KREHA3)
Effekterna av excentrisk jämfört med standardstyrkaträning i rehabilitering av primär ryggmärgsskada - en matchad par -randomiserad kontrollerad studie
The goal of this clinical trial is to assess the effects of eccentric arm-crank (KREHA) training compared to standard clinical routine strength (STAN) training in individuals undergoing primary spinal cord injury (SCI) rehabilitation.
The main questions this trail aims to answer are:
- what are the effects of the training on upper body strength, aerobic performance, muscle volume, functional independence, and health-related quality of life?
- is the KREHA training feasible to implement into the rehabilitation routine?
Participants will:
- perform either 20 KREHA sessions or 20 STAN sessions within 12 weeks
- perform a test battery to collect data on training effects before (pretest) and after (posttest) the study intervention
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Fabian Ammann, MSc
- Telefonnummer: +41419396624
- E-post: fabian.ammann@paraplegie.ch
Studera Kontakt Backup
- Namn: Anneke Hertig-Godeschalk, PhD
- Telefonnummer: +414 9396603
- E-post: anneke.hertig@paraplegie.ch
Studieorter
-
-
Canton of Lucerne
-
Nottwil, Canton of Lucerne, Schweiz, 6207
- Swiss Paraplegic Centre
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- 18 years or older.
- informed consent as confirmed per signature.
- traumatic or disease-related SCI.
- participating in the routine strength training program during primary SCI rehabilitation at the study center (generally this is initiated around one month after SCI onset).
- wheelchair dependency during activities of daily living, defined by a score of 0-2 in the SCIM subsection regarding "Mobility in the house".
- passed sports medical assessment and having sufficient biceps/triceps function to perform arm-crank training, as determined by an experienced sports medicine physician
Exclusion Criteria:
- inflammatory or neurodegenerative diseases (including multiple sclerosis or Guillain-Barré syndrome).
- comorbidities or other health issues that may interfere with study participation, inability or contraindications to undergo the investigated intervention.
- MRI contraindications (magnetic metal parts or electronic implants such as pacemakers in the body).
- pregnancy (anamnestic).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Eccentric arm-crank (KREHA) training
The eccentric training intervention consists of 20 training sessions performed on a symmetric arm-crank (Krafttraining mittels exzentrischer Handkurbel, KREHA) device. The training sessions have a duration of approximately 30 min and will be completed within twelve weeks, with a maximum of three sessions per week. |
20 eccentric resistance training sessions will be performed on a symmetric arm-crank ergometer in a supine position. |
|
Aktiv komparator: Standard clinical routine strength (STAN) training
The standard strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. The training sessions have a duration of approximately 60 min and will be completed within twelve weeks, with around three sessions per week. |
The regular strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Upper body strength
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength will be measured by a one-repetition maximum (1RM) bench press (in kg). The maximum amount of weight that can be pushed upwards for one repetition, while lying in a supine position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Upper body strength
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength measured by a 1RM bench pull (in kg). The maximum amount of weight that can be pulled upwards for one repetition, while lying in a prone position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
|
Handgrip strength
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in maximum strength of three handgrip measurements (in kg) of both hands using a Jamar Handgrip Dynamometer. |
< 1 week pre and 12 weeks post intervention start.
|
|
Aerobic performance
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in cardiopulmonary adaptations, measured by aerobic performance in an exercise test on a regular arm-crank ergometer. A ramp protocol starting at 20 Watt followed by 1 Watt / 6 sec increments to failure will be used. The following parameters will be evaluated during this aerobic endurance test: power at failure at the end of the test (in Watt), peak oxygen uptake during the test (in ml/kg/min), maximal heart rate (bpm) |
< 1 week pre and 12 weeks post intervention start.
|
|
Muscle volume
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Magnetic resonance imaging (MRI) of relevant upper body muscles of the dominant upper arm and shoulder will be used to measure change in muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Arm circumference
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in arm circumference of the right and left lower and upper arm (in cm), will be used to estimate muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Functioning during activities of daily living
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in functioning during activities of daily living will be assessed by the Spinal Cord Independence Measure (SCIM) as extracted from clinical records. The SCIM total score ranges from 0-100, with higher scores indicating higher levels of functional independence. |
< 1 week pre and 12 weeks post intervention start.
|
|
Health-related quality of life
Tidsram: < 1 week pre and 12 weeks post intervention start.
|
Change in health-related quality of life will be assessed using the Short Form Health Survey (SF-12). Weighted physical and mental component scores range from 0-100, with higher scores indicating better physical or mental health. |
< 1 week pre and 12 weeks post intervention start.
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Feasibility of the KREHA training (total number of training sessions)
Tidsram: Throughout the intervention phase, week 0-12
|
Successful implementation of the KREHA training in the clinical routine, by assessing whether the 20 KREHA sessions are completed within 12 weeks. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (number of sessions adapted)
Tidsram: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how many training sessions needed to be adapted. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (power adaptation)
Tidsram: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how much the target power (in Watts) of a training session needed to be adapted compared to the initially planned progression. |
Throughout the intervention phase, week 0-12
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2023-21
- SNCTP000006132 (Annan identifierare: Swiss National Clinical Trials Portal)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .